Evidence map›Paper›PMID 37721926›Full record

ArticlePLOS global public health2023

HIV, syphilis, and hepatitis B virus infection and male circumcision in five Sub-Saharan African countries: Findings from the Population-based HIV Impact Assessment surveys, 2015-2019.

Megan E Peck, Megan Bronson, Gaston Djomand, Ikuzo Basile, Kamanzi Collins, Ida Kankindi, Eugenie Kayirangwa, Samuel S Malamba, Veronicah Mugisha, Sabin Nsanzimana and 22 more

Abstract read
In one paragraph

Article in PLOS global public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Megan E PeckDivision of Global HIV & TB, HIV Prevention Branch, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, United States of America.ORCID https://orcid.org/0000-0002-2447-6324
Megan BronsonDivision of Global HIV & TB, Epidemiology and Surveillance Branch, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, United States of America.
Gaston DjomandDivision of Global HIV & TB, HIV Prevention Branch, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, United States of America.
Ikuzo BasileMinistry of Health, Rwanda Biomedical Center, Kigali City, Rwanda.
Kamanzi CollinsICAP at Columbia University, Kigali City, Rwanda.ORCID https://orcid.org/0009-0007-7268-3380
Ida KankindiDivision of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Kigali, Rwanda.
Eugenie KayirangwaDivision of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Kigali, Rwanda.
Samuel S MalambaDivision of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Kigali, Rwanda.
Veronicah MugishaICAP at Columbia University, Kigali City, Rwanda.ORCID https://orcid.org/0000-0002-2159-4800
Sabin NsanzimanaMinistry of Health, Rwanda Biomedical Center, Kigali City, Rwanda.
Eric RemeraMinistry of Health, Rwanda Biomedical Center, Kigali City, Rwanda.
Kokuhumbya J KazauraDivision of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Dar-es-Salaam, Tanzania.
Mbaraka AmuriDivision of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Dar-es-Salaam, Tanzania.ORCID https://orcid.org/0000-0002-8583-9555
Susan MmbandoNational AIDS Control Program, Ministry of Health, Dar-es-Salaam, Tanzania.
George S MgomellaDivision of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Dar-es-Salaam, Tanzania.
Daimon SimbeyeDivision of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Dar-es-Salaam, Tanzania.
Anna Colletar AworDivision of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Kampala, Uganda.
Samuel BiraroColumbia University, Kampala, Uganda.
Geoffrey KabuyeDivision of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Kampala, Uganda.
Wilford KirungiMinistry of Health, Kampala, Uganda.
Omega ChituwoDivision of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Lusaka, Zambia.
Brave HanunkaDivision of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Lusaka, Zambia.
Royd KamboyiDepartment of Public Health, Ministry of Health, Lusaka, Zambia.
Lloyd MulengaDepartment of Public Health, Ministry of Health, Lusaka, Zambia.
Bupe MusondaDepartment of Public Health, Ministry of Health, Lusaka, Zambia.
Brian MuyundaDivision of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Lusaka, Zambia.
Tepa NkumbulaICAP at Columbia University, Lusaka, Zambia.
Rickie MalabaDivision of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Harare, Zimbabwe.
John MandisarisaDivision of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Harare, Zimbabwe.
Godfrey MusukaICAP at Columbia University, Harare, Zimbabwe.ORCID https://orcid.org/0000-0001-9077-4429
Amy E PetersonDivision of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Harare, Zimbabwe.ORCID https://orcid.org/0000-0002-3567-7156
Carlos ToledoDivision of Global HIV & TB, HIV Prevention Branch, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Voluntary medical male circumcision (VMMC) has primarily been promoted for HIV prevention. Evidence also supports that male circumcision offers protection against other sexually transmitted infections. This analysis assessed the effect of circumcision on syphilis, hepatitis B virus (HBV) infection and HIV. Data from the 2015 to 2019 Population-based HIV Impact Assessments (PHIAs) surveys from Rwanda, Tanzania, Uganda, Zambia, and Zimbabwe were used for the analysis. The PHIA surveys are cross-sectional, nationally representative household surveys that include biomarking testing for HIV, syphilis and HBV infection. This is a secondary data analysis using publicly available PHIA data. Univariate and multivariable logistic regression models were created using pooled PHIA data across the five countries to assess the effect of male circumcision on HIV, active and ever syphilis, and HBV infection among sexually active males aged 15-59 years. Circumcised men had lower odds of syphilis infection, ever or active infection, and HIV, compared to uncircumcised men, after adjusting for covariates (active syphilis infection = 0.67 adjusted odds ratio (aOR), 95% confidence interval (CI), 0.52-0.87, ever having had a syphilis infection = 0.85 aOR, 95% CI, 0.73-0.98, and HIV = 0.53 aOR, 95% CI, 0.47-0.61). No difference between circumcised and uncircumcised men was identified for HBV infection (P = 0.75). Circumcised men have a reduced likelihood for syphilis and HIV compared to uncircumcised men. However, we found no statistically significant difference between circumcised and uncircumcised men for HBV infection.

Identifiers

PMID37721926
PMCPMC10506706

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.